Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1Phase 1/2 1

Status

Active not recruiting 8Recruiting 7Completed 5Unknown 3Not yet recruiting 3Withdrawn 1Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 4Head & Neck 3Gastrointestinal 3Tumor-Agnostic 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Endocrine 1Dermatologic 1CNS 1

Conditions

Thyroid Neoplasms 2Neoplasms 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Ovarian Neoplasms 1Neoplasms by Site 1Neoplasms by Histologic Type 1Multiple Myeloma 1Melanoma 1Lymphoproliferative Disorders 1Laryngeal Neoplasms 1Histiocytosis, Langerhans-Cell 1Hematologic Neoplasms 1Glioma 1Gastrointestinal Neoplasms 1Erdheim-Chester Disease 1

Interventions

Cisplatin 28toripalimab 14Radiotherapy 12Gemcitabine 12Capecitabine 11Radiotherapy, Intensity-Modulated 10pembrolizumab 9Surgical Procedures, Operative 9Docetaxel 9tislelizumab 8Carboplatin 7Drug Therapy 6Blood Specimen Collection 6anlotinib 5Taxes 5Paclitaxel 5Nivolumab 5Magnetic Resonance Spectroscopy 5Fluorouracil 5Cetuximab 5Thyroxine 4Cyclophosphamide 4130-nm albumin-bound paclitaxel 4trametinib 3sintilimab 3camrelizumab 3Specimen Handling 3Radiation 3Observation 3Injections 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × trametinib × Head & Neck × Clear all
NCT07440290 2026-02-27

DETERMINE

Cancer Research UK

Phase 2/3 Not yet recruiting
30 enrolled
CNSEndocrineGastrointestinalGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Glioma, Histiocytosis, Langerhans-Cell, Laryngeal Neoplasms, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

NCT07010393 2025-06-08

Genotype-Driven Neoadjuvant Therapy for Locally Advanced Thyroid Cancer: A Real-World Cohort Study

Fujian Medical University

Phase 4 Not yet recruiting
335 enrolled
Head & Neck

Thyroid Neoplasms

NCT05275374 2025-04-10

ENHANCE

Xynomic Pharmaceuticals, Inc.

Phase 1/2 Not yet recruiting
221 enrolled
DermatologicGastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡